86 related articles for article (PubMed ID: 7411554)
1. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities.
Glennon RA; Liebowitz SM; Leming-Doot D; Rosecrans JA
J Med Chem; 1980 Sep; 23(9):990-4. PubMed ID: 7411554
[TBL] [Abstract][Full Text] [Related]
2. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
Glennon RA; Liebowitz SM; Mack EC
J Med Chem; 1978 Aug; 21(8):822-5. PubMed ID: 278843
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Glennon RA; Young R; Benington F; Morin RD
J Med Chem; 1982 Oct; 25(10):1163-8. PubMed ID: 7143352
[TBL] [Abstract][Full Text] [Related]
4. Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Glennon RA; Liebowitz SM; Anderson GM
J Med Chem; 1980 Mar; 23(3):294-9. PubMed ID: 7365744
[TBL] [Abstract][Full Text] [Related]
5. Benzofuran bioisosteres of hallucinogenic tryptamines.
Tomaszewski Z; Johnson MP; Huang X; Nichols DE
J Med Chem; 1992 May; 35(11):2061-4. PubMed ID: 1534585
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines.
Glennon RA; Jacyno JM; Young R; McKenney JD; Nelson D
J Med Chem; 1984 Jan; 27(1):41-5. PubMed ID: 6581313
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
8. Investigation of hallucinogenic and related beta-carbolines.
Grella B; Dukat M; Young R; Teitler M; Herrick-Davis K; Gauthier CB; Glennon RA
Drug Alcohol Depend; 1998 Apr; 50(2):99-107. PubMed ID: 9649961
[TBL] [Abstract][Full Text] [Related]
9. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.
Glennon RA; McKenney JD; Lyon RA; Titeler M
J Med Chem; 1986 Feb; 29(2):194-9. PubMed ID: 3950904
[TBL] [Abstract][Full Text] [Related]
11. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.
Lyon RA; Titeler M; Seggel MR; Glennon RA
Eur J Pharmacol; 1988 Jan; 145(3):291-7. PubMed ID: 3350047
[TBL] [Abstract][Full Text] [Related]
12. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
[TBL] [Abstract][Full Text] [Related]
13. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
14. Potential psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene analogs.
Barfknecht CF; Nichols DE; Rusterholz DB; Long JP; Engelbrecht JA; Beaton JM; Bradley RJ; Dyer DC
J Med Chem; 1973 Jul; 16(7):804-8. PubMed ID: 4725926
[No Abstract] [Full Text] [Related]
15. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
[TBL] [Abstract][Full Text] [Related]
16. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.
Glennon RA; Slusher RM; Lyon RA; Titeler M; McKenney JD
J Med Chem; 1986 Nov; 29(11):2375-80. PubMed ID: 3783595
[TBL] [Abstract][Full Text] [Related]
18. In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Zweig JS; Castagnoli N
J Med Chem; 1977 Mar; 20(3):414-21. PubMed ID: 845874
[TBL] [Abstract][Full Text] [Related]
19. 2,3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines.
Nichols DE; Snyder SE; Oberlender R; Johnson MP; Huang XM
J Med Chem; 1991 Jan; 34(1):276-81. PubMed ID: 1992127
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
Ismaiel AM; De Los Angeles J; Teitler M; Ingher S; Glennon RA
J Med Chem; 1993 Aug; 36(17):2519-25. PubMed ID: 8355253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
